Get Free Delivery With No Minimum Order

GYNERA TAB 21/TAB
- Sku : I-002731
Key features
Gynera 21 Coated Tablet 30,75 µg is a combined oral contraceptive containing ethinylestradiol 30 µg and gestodene 75 µg. It works by suppressing ovulation, thickening cervical mucus, and causing endometrial changes that make pregnancy less likely. It is used for oral contraception. This product is supplied as coated tablets in a pack of 21 tablets.- Brand: GYNERA
- Active Ingredient: ETHINYLESTRADIOL 30µg, GESTODENE 75µg
- Strength: 30,75µg
- Dosage Form: Coated tablet
- Pack Size: 21 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Contraceptive
- Pharmacological Group: Hormonal Contraceptives
- Drug Class: Combined oral contraceptive (COC): ethinylestradiol (estrogen) + gestodene (third‑generation progestin), monophasic 21‑day formulation.
- Manufacturer: BAYER AG
- Country of Origin: Germany
- SFDA Registration No.: 0206222126
- Shelf Life: 24 months
- Storage: do not store above 30°c
- Hormone Type: Combined
- Method: Oral
Indications
Approved Uses
Oral contraception
Dosage & Administration
Dosing by Condition
Contraception: 1 tablet orally daily for 21 days, then 7 days tablet‑free; repeat with the next pack starting on day 8.
Maintenance Dose
One tablet daily for 21 days followed by 7 tablet-free days
Maximum Dose
1 tablet orally once daily (ethinylestradiol 30 µg/gestodene 75 µg) as per the verified strength and oral dosage form.
Side Effects
Common Side Effects
Nausea, headache, breast tenderness or pain, breakthrough bleeding or spotting, mood changes, decreased libido, weight changes, contact lens intolerance
Side Effect Frequency
Common (≥1% to <10%): nausea, abdominal pain, headache, breast pain/tenderness, mood changes, weight change, and irregular uterine bleeding/spotting; Rare/very rare: venous and arterial thromboembolic events.
Special Populations
Pregnancy
Contraindicated
Pharmacology
Mechanism of Action
Suppresses ovulation via inhibition of gonadotropins (FSH/LH), thickens cervical mucus to impede sperm penetration, and induces endometrial changes that reduce the likelihood of implantation.
Bioavailability
Ethinylestradiol: ~45% (variable due to first-pass metabolism). Gestodene: ~99%.
Product Information
Available Dosage Forms
Coated tablet (oral)
Composition per Dose
Each coated tablet: Ethinylestradiol 30µg + Gestodene 75µg
Hormone Type
Combined
Method
Oral
Legal Disclaimer - Al Mujtama Pharmacy The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment. Al Mujtama Pharmacy assumes no legal or medical liability for: Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist Any discrepancy between the information provided and the product's package insert or SFDA guidelines Any misuse of medication resulting from personal interpretation of the content displayed Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication. By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation. Your health is a trust - always consult your doctor first.-1744229570.gif)





